ZNF384 and precursor B-cell acute lymphoblastic leukemia: In 2015, Ohara’s group isolated a novel recurrent histone acetyltransferase p300 (EP300)-ZNF384 gene fusion, found in about 1.5% of pediatric B-ALL and showing clinical features significantly different from the other ZNF384-positive patients.